Literature DB >> 1310684

The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.

B E Bejcek1, R M Hoffman, D Lipps, D Y Li, C A Mitchell, P W Majerus, T F Deuel.   

Abstract

The v-sis oncogene product p28v-sis and the platelet-derived growth factor (PDGF) B chain share 92% homology with each other and over 50% homology with the PDGF A chain. Exogenously added homodimers of PDGF A and PDGF B and of p28v-sis are potent mitogens but only PDGF B and p28v-sis induce transformation when endogenously expressed with a strong promoter. Because exogenous PDGF AA and PDGF BB both initiate a full mitogenic response, understanding the mechanisms underlying the difference in their transforming potential may clarify how growth factor genes act as oncogenes. In this work, we compared cells expressing high levels of PDGF A and v-sis. We observed that transformation by v-sis correlated directly with the rapid degradation (t1/2 approximately 20 min) of the alpha and beta PDGF receptors, with a failure of either the alpha or beta receptor to be fully processed and with the association of high levels of phosphatidylinositol (PI) 3-kinase with immunoprecipitates of the PDGF receptors. In contrast, in cells expressing essentially equal levels of PDGF A, transformation was not detected, alpha and beta PDGF receptor processing was normal, and association of PI 3-kinase with receptors in immunoprecipitates was not found above control values. The ability of v-sis to autoactivate PDGF receptors within processing compartments and to initiate activation of the PI 3-kinase signaling pathway coupled with the failure of PDGF A to activate its receptor intracellularly and to induce transformation when endogenously expressed at high levels suggests that the internal autoactivation of PDGF receptors may be essential for transformation by v-sis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice.

Authors:  Chieh-Fang Cheng; Divya Sahu; Fred Tsen; Zhengwei Zhao; Jianhua Fan; Rosie Kim; Xinyi Wang; Kathryn O'Brien; Yong Li; Yuting Kuang; Mei Chen; David T Woodley; Wei Li
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

3.  De novo generation of permanent neovascularized soft tissue appendages by platelet-derived growth factor.

Authors:  R K Khouri; S P Hong; E G Deune; J E Tarpley; S Z Song; C M Serdar; G F Pierce
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.

Authors:  Carolyn V Ustach; Hyeong-Reh Choi Kim
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  An S1 nuclease-sensitive region in the first intron of human platelet-derived growth factor A-chain gene contains a negatively acting cell type-specific regulatory element.

Authors:  Z Y Wang; N Masaharu; Q Q Qiu; Y Takimoto; T F Deuel
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

6.  A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression.

Authors:  Carolyn V Ustach; Marcus E Taube; Newton J Hurst; Sunita Bhagat; R Daniel Bonfil; Michael L Cher; Lucia Schuger; Hyeong-Reh Choi Kim
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

7.  Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.

Authors:  A K Chauhan; Y S Li; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

8.  Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.

Authors:  S M Shamah; C D Stiles; A Guha
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

9.  The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.

Authors:  K C Hart; Y F Xu; A N Meyer; B A Lee; D J Donoghue
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

Review 10.  Wound Healing Driver Gene and Therapeutic Development: Political and Scientific Hurdles.

Authors:  Xin Tang; Michelle Hao; Cheng Chang; Ayesha Bhatia; Kathrine O'Brien; Mei Chen; David G Armstrong; Wei Li
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-10-28       Impact factor: 4.947

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.